Lantheus Holdings, Inc.: insider trades.
Lantheus Holdings, Inc. reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($1.3M), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- Lantheus Holdings, Inc.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | TenPercentOwner | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-04 | Perspective Therapeutics, Inc. | S | 167,149 | $3.15 | 11,273,364 | Form 4 |
| 2026-09-03 | Perspective Therapeutics, Inc. | S | 80,783 | $3.11 | 11,440,513 | Form 4 |
| 2026-09-02 | Perspective Therapeutics, Inc. | S | 42,129 | $3.11 | 11,521,296 | Form 4 |
| 2026-09-01 | Perspective Therapeutics, Inc. | S | 35,769 | $3.12 | 11,563,425 | Form 4 |
| 2026-08-31 | Perspective Therapeutics, Inc. | S | 78,145 | $3.14 | 11,599,194 | Form 4 |
Questions
What stock did Lantheus Holdings, Inc. buy or sell?
Lantheus Holdings, Inc. reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($1.3M), across 1 company.
Is Lantheus Holdings, Inc. the same person as other filers with this name?
This page covers SEC CIK 1521036 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/lantheus-holdings-inc-1521036.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.